Searched for
GENERIC MIGRAINE TREATMENT
Cipla gets USFDA nod for migraine drugThe newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline's Imitrex Nasal Spray.
Lupin gets USFDA nod to market its mania and epilepsy treatment drug in USThe company has received approval from the United States Food and Drug Administration (USFDA) for its Divalproex Sodium extended-release ta...
Ajanta Pharma gets USFDA nod for migraine pain relief drugAjanta Pharma has received final approval for its generic version of acute migraine pain relief drug Zolmitriptan tablets from the US healt...
Aurobindo Pharma gets USFDA nod for generic migraine drugThe company's product is the generic equivalent of IPR Pharmaceuticals' Zomig, which is used in the treatment of migraine in adults.
Dr Reddy’s goes beyond generic products, gets nod for two branded drugsThe approvals have come at a time when Indian drug companies are facing the FDA’s ire for non-compliance of good manufacturing process.
Jubilant Life Sciences gets USFDA nod for migraine treatment drugJubilant Life Sciences announced approval from the US health regulator for its generic version of Merck's acute migraine treatment medicine.
Jubilant Life gets USFDA nod for anti-migraine tabletsJubilant Life Sciences today said it has received US health regulator's nod to market its generic zolmitriptan orally disintegrating tablet...
Jubilant Life Sciences gets FDA nod for Mycophenolate Mofetil & RizatriptanThe approvals are for Mycophenolate Mofetil in the strengths of 250 mg capsules and 500 mg tablets and Rizatriptan tablets in strengths of ...
Aurobindo Pharma gets USFDA final nod for migraine tabletsAurobindo Pharma today said it has received final approval from the US health regulator to manufacture Rizatriptan Benzoate tablets.
Glenmark gets USFDA approval for headache drug"Glenmark will commence distribution of the product immediately," the Mumbai-based firm said.
Aurobindo Pharma gets USFDA nod for anti-migraine tabletsThe product which was tentatively approved by the FDA earlier, is ready for launch, a statement from Aurobindo said.
- Sun Pharma gets USFDA approval for migraine injection
Sun Pharma said it has received the USFDA approval for the launch of its generic Sumatriptan Succinate injections in the American market.
- Sun Pharma gets approval form USFDA for Depakote Tablet
Sun Pharmaceutical has received tentative approval for the abbreviated new drug application--generic Depakote , divalproex sodium delayed r...
- Aurobindo Pharma gets USFDA nod for Sumatriptan
Aurobindo Pharma has received tentative approval from the US Food and Drug Administration to manufacture and market Sumatriptan Succinate t...
- Abbott files patent suit against Zydus Cadila in US court
US-based Abbott Laboratories seeks to stop the Indian company, Zydus Cadila, from selling generic version of its drug, Depakote, in the US.
- Glenmark gets tentative FDA nod for Topiramte
Glenmark Pharmaceuticals says it has received the USFDA tentative approval to market Topiramate tablets.
- DRL settles Imitrex lawsuit with GlaxoSmithKline
Domestic pharma major Dr Reddy's Laboratories Ltd on Tuesday announced the settlement of the patent litigation with GlaxoSmithKline relatin...